Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22139358 | 0.80 | XIAP (0.39) | XIAPMAPTHTTMEN1KMT2A | |
| SCHEMBL22139376 | 0.80 | HSP90AA1 (0.30) | — | |
| SCHEMBL22139372 | 0.72 | ALOX5 (0.34) | XIAPMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL22139397 | 0.72 | XIAP (0.41) | XIAPMAPTHTTPKMALDH1A1 | |
| SCHEMBL22139361 | 0.69 | XIAP (0.35) | XIAP | |
| SCHEMBL22139373 | 0.69 | MAPK1 (0.43) | XIAPMAPTHTTMEN1KMT2A | |
| SCHEMBL9747012 | 0.63 | MAPT (0.49) | MAPTHTTMEN1KMT2ALMNA | |
| SCHEMBL9747014 | 0.63 | MAPT (0.49) | MAPTHTTMEN1KMT2ALMNA | |
| SCHEMBL14283805 | 0.61 | ALOX5 (0.51) | MAPTHTTMEN1KMT2ALMNA | |
| SCHEMBL22139360 | 0.61 | KDM4E (0.34) | XIAPMAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200199058-A1 | SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES | NITTO DENKO CORPORATION (JP) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199058-A1 | SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES | SQLE, FDFT1, ALDH1A2 | XIAP 930/4885MAPT 3928/4885HTT 4723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.